Cadila Healthcare Sees Large Gain In Japan From Import Duty Change
This article was originally published in PharmAsia News
Executive Summary
Cadila Healthcare expects to be a big winner in the wake of Japan's reduction in duties on Indian generic drugs, but also is looking to The Philippines, South Africa and Mexico as other lucrative markets.